Hodgkin Disease

Oncology·MeSH: Hodgkin Disease

3 drugs in development·3 companies·7 clinical trials

Drug Pipeline by Phase

Phase 1(1)

Drug	Company
pf-08046044/sgn-35c	PFIZER INC (PFE)

Phase 4(2)

Drug	Company
vinblastine	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
vinblastine	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

BioSniper tracks 3 drugs in development for Hodgkin Disease across 3 companies.

There are 7 clinical trials targeting Hodgkin Disease tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.